Risini D. Weeratna

4.5k total citations · 1 hit paper
58 papers, 3.6k citations indexed

About

Risini D. Weeratna is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Risini D. Weeratna has authored 58 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 20 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Risini D. Weeratna's work include Immunotherapy and Immune Responses (32 papers), Immune Response and Inflammation (29 papers) and CAR-T cell therapy research (9 papers). Risini D. Weeratna is often cited by papers focused on Immunotherapy and Immune Responses (32 papers), Immune Response and Inflammation (29 papers) and CAR-T cell therapy research (9 papers). Risini D. Weeratna collaborates with scholars based in Canada, United States and Germany. Risini D. Weeratna's co-authors include Heather L. Davis, Michael J. McCluskie, Arthur Μ. Krieg, Paul Payette, Cynthia L. Brazolot Millan, Jürgen Vollmer, Claire‐Anne Siegrist, Marion Jurk, Christian Schetter and Yu Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Risini D. Weeratna

58 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

2000 507 citations Gunther Hartmann, Risini D. Weeratna et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Risini D. Weeratna Canada	29	2.6k	1.1k	746	420	408	58	3.6k
Ugo D’Oro Italy	31	1.6k 0.6×	1.1k 1.0×	722 1.0×	256 0.6×	359 0.9×	56	2.9k
Michael J. McCluskie Canada	33	2.1k 0.8×	939 0.9×	1.1k 1.4×	367 0.9×	686 1.7×	82	3.6k
Sandra Nuti Italy	27	1.9k 0.7×	556 0.5×	1.1k 1.4×	365 0.9×	325 0.8×	54	3.2k
A M Krieg United States	30	4.9k 1.9×	2.1k 2.0×	949 1.3×	637 1.5×	491 1.2×	46	6.6k
Frederik W. van Ginkel United States	32	1.4k 0.5×	795 0.8×	1.1k 1.4×	469 1.1×	694 1.7×	56	3.4k
Muguette Jéhanno France	12	1.3k 0.5×	769 0.7×	366 0.5×	263 0.6×	237 0.6×	17	2.1k
Timothy J. Sellati United States	34	2.0k 0.8×	1.2k 1.1×	663 0.9×	568 1.4×	1.2k 3.0×	49	4.2k
Mary Jo Wick Sweden	35	2.5k 1.0×	963 0.9×	428 0.6×	193 0.5×	756 1.9×	70	4.1k
Lionel Le Bourhis France	32	4.4k 1.7×	1.5k 1.4×	1.6k 2.2×	427 1.0×	690 1.7×	50	6.5k
Gary A. Jarvis United States	35	1.0k 0.4×	834 0.8×	773 1.0×	1.2k 3.0×	407 1.0×	76	3.0k

Countries citing papers authored by Risini D. Weeratna

Since Specialization

Citations

This map shows the geographic impact of Risini D. Weeratna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risini D. Weeratna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risini D. Weeratna more than expected).

Fields of papers citing papers by Risini D. Weeratna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risini D. Weeratna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risini D. Weeratna. The network helps show where Risini D. Weeratna may publish in the future.

Co-authorship network of co-authors of Risini D. Weeratna

This figure shows the co-authorship network connecting the top 25 collaborators of Risini D. Weeratna. A scholar is included among the top collaborators of Risini D. Weeratna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risini D. Weeratna. Risini D. Weeratna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lalu, Manoj M., Natasha Kekre, Matthew S. Jeffers, et al.. (2025). Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis. Transfusion Medicine Reviews. 39(2). 150897–150897. 1 indexed citations

Bloemberg, Darin, et al.. (2021). Self-Cutting and Integrating CRISPR Plasmids Enable Targeted Genomic Integration of Genetic Payloads for Rapid Cell Engineering. The CRISPR Journal. 4(1). 104–119. 3 indexed citations

Haq, Kamran, Yimei Jia, Seyyed Mehdy Elahi, et al.. (2019). Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen. Vaccine. 37(47). 7029–7040. 13 indexed citations

Weeratna, Risini D., Ghania Chikh, Lu Zhang, et al.. (2016). Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates. Immunity Inflammation and Disease. 4(2). 135–147. 7 indexed citations

Anderson, Richard J., Siradanahalli C. Guru, Risini D. Weeratna, et al.. (2016). In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity. Vaccine. 34(50). 6292–6300. 10 indexed citations

Forsbach, Alexandra, Christian Müller, Toan B. Nguyen, et al.. (2012). Negative Regulation of the Type I Interferon Signaling Pathway by Synthetic Toll-Like Receptor 7 Ligands. Journal of Interferon & Cytokine Research. 32(6). 254–268. 7 indexed citations

Samulowitz, Ulrike, Markus Weber, Risini D. Weeratna, et al.. (2010). A Novel Class of Immune-Stimulatory CpG Oligodeoxynucleotides Unifies High Potency in Type I Interferon Induction with Preferred Structural Properties. Oligonucleotides. 20(2). 93–101. 66 indexed citations

McCluskie, Michael J., et al.. (2005). Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral Research. 69(2). 77–85. 33 indexed citations

Vollmer, Jürgen, Risini D. Weeratna, Marion Jurk, et al.. (2004). Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll‐like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology. 113(2). 212–223. 116 indexed citations

10.

Vollmer, Jürgen, Risini D. Weeratna, Paul Payette, et al.. (2003). Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. European Journal of Immunology. 34(1). 251–262. 481 indexed citations

11.

Weeratna, Risini D., Arthur Μ. Krieg, & Heather L. Davis. (2003). Immunostimulatory CpG Motifs and DNA Vaccines. Humana Press eBooks. 29. 169–172. 1 indexed citations

12.

McCluskie, Michael J., Risini D. Weeratna, Paul Payette, & Heather L. Davis. (2002). Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunology & Medical Microbiology. 32(3). 179–185. 76 indexed citations

13.

Weeratna, Risini D., Cynthia L. Brazolot Millan, Michael J. McCluskie, & Heather L. Davis. (2001). CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunology & Medical Microbiology. 32(1). 65–71. 81 indexed citations

14.

Weeratna, Risini D., Cynthia L. Brazolot Millan, Michael J. McCluskie, Claire‐Anne Siegrist, & Heather L. Davis. (2001). Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies. FEMS Immunology & Medical Microbiology. 30(3). 241–247. 33 indexed citations

15.

Weeratna, Risini D., et al.. (2001). The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants. Vaccine. 19(17-19). 2657–2660. 43 indexed citations

16.

Hartmann, Gunther, Risini D. Weeratna, Zuhair K. Ballas, et al.. (2000). Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo. The Journal of Immunology. 164(3). 1617–1624. 507 indexed citations breakdown →

17.

McCluskie, Michael J., Risini D. Weeratna, Arthur Μ. Krieg, & Heather L. Davis. (2000). CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine. 19(7-8). 950–957. 87 indexed citations

18.

McCluskie, Michael J., Risini D. Weeratna, & Heather L. Davis. (2000). The role of CpG in DNA vaccines. Springer Seminars in Immunopathology. 22(1-2). 125–132. 39 indexed citations

19.

Weeratna, Risini D., et al.. (2000). Optimization Strategies for DNA Vaccines. Intervirology. 43(4-6). 218–226. 9 indexed citations

20.

McCluskie, Michael J., Risini D. Weeratna, & Heather L. Davis. (2000). Intranasal Immunization of Mice with CpG DNA Induces Strong Systemic and Mucosal Responses That Are Influenced by Other Mucosal Adjuvants and Antigen Distribution. Molecular Medicine. 6(10). 867–877. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact